Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus
- PMID: 22677006
- PMCID: PMC3412361
- DOI: 10.1016/j.jcv.2012.05.005
Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus
Abstract
Background: Human metapneumovirus (HMPV) is a paramyxovirus with multiple genetic lineages that is a leading cause of acute respiratory disease. Several RT-PCR assays have been described based on limited available sequence data.
Objectives: To develop a broadly reactive real-time RT-PCR assay for HMPV that allows for a rapid, sensitive, and specific detection in a clinical or research setting.
Study design: Three published assays for HMPV were modified based on analysis of multiple HMPV sequences obtained from GenBank. Original and modified assays were tested against prototype HMPV strains from each genetic sublineage, multiple isolates of HMPV from different years, a collection of clinical specimens, and commercial validation panels.
Results: A number of potential sequence mismatches with diverse HMPV strains were identified. Modifications were made to oligonucleotides to improve annealing efficiency. Primers and probes based on newer sequence data offered enhanced detection of all subgroups, especially for low titer specimens. The new primers and probe detected multiple clinical isolates of HMPV collected over a twenty-year period. The modified assay improved detection of HMPV in a panel of clinical specimens, and correctly identified HMPV samples in two commercial validation sets.
Conclusions: We report a modified real-time RT-PCR assay for HMPV that detects all genetic lineages with high sensitivity.
Copyright © 2012 Elsevier B.V. All rights reserved.
Figures
References
-
- Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. J Infect Dis. 2003;187:785–90. - PubMed
-
- McAdam AJ, Hasenbein ME, Feldman HA, Cole SE, Offermann JT, Riley AM, et al. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004;190:20–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL072471/HL/NHLBI NIH HHS/United States
- TL1 RR024978/RR/NCRR NIH HHS/United States
- UL1-RR024975/RR/NCRR NIH HHS/United States
- R21 AI082417/AI/NIAID NIH HHS/United States
- AI-074863/AI/NIAID NIH HHS/United States
- UL1 RR024975/RR/NCRR NIH HHS/United States
- AI-085062/AI/NIAID NIH HHS/United States
- AI-82417/AI/NIAID NIH HHS/United States
- K24 AI077930/AI/NIAID NIH HHS/United States
- N01 AI025462/AI/NIAID NIH HHS/United States
- K23 AI074863/AI/NIAID NIH HHS/United States
- R01 AI085062/AI/NIAID NIH HHS/United States
- AI-077930/AI/NIAID NIH HHS/United States
- U01 HL-072471/HL/NHLBI NIH HHS/United States
- KL2 RR024977/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
